header-22.jpg
Events

APCRC-Q Seminar Series - Dr Kieran Scott & Dr Anja Rockstroh

What's new in prostate cancer research? Join Senior Research Fellow and Associate Professor, Dr Kieran Scott at this APCRC-Q Seminar Series Event. Dr Scott and Dr Rockstroh will share their current research activities in the area of prostate cancer. This regular seminar series aims to bring together scientists, researchers, and clinicians from a cross-section of disciplines, enabling them to share discoveries and discuss the significance of their work in the treatment of prostate cancer.
Event Type Seminar
When Mar 29, 2012
from 08:45 PM to 10:45 PM
Where Russell Strong Auditorium, PA Hospital
Contact Name
Contact Phone 3176 1894
Add event to calendar vCal
iCal

"Targeting arachidonic acid metabolism in prostate cancer."


Dr Kieran Scott

Dr Kieran Scott

Senior Research Fellow
St Vincent’s Hospital Clinical School
University of New South Wales

Dr Scott trained in Chemistry and Biochemistry at Massey University, New Zealand before completing his PhD in Genetics at the Research School of Biological Sciences, ANU in the early eighties. There he cloned the bacterial genes encoding nitrogenase, the enzyme that makes atmospheric nitrogen available to living organisms.

Following several years at ANU, using reversed genetics techniques that were the forerunners of “knockout mouse” technology to clone and characterise bacterial genes involved in bacterial-plant interactions, he joined a Sydney start-up biotechnology company “PacBio” where his interest in the pathways of arachidonic acid metabolism as targets for new drug development began.

In the early nineties, he established the Inflammation Research Laboratory in the St Vincent’s Hospital Clinical School, UNSW, which became the founding laboratory of the Arthritis and Inflammation Research Programme of the Garvan Institute, Sydney.

Dr Scott’s research interests in phospholipase A2 enzymes as targets for new drug development have led him to study their role in clinical disorders ranging from sepsis and septic shock to asthma, rheumatoid arthritis, atherosclerosis, reperfusion injury and more recently cancer. His work has led to a promising new therapeutic approach to the treatment of prostate cancer that is approaching the clinic.

 

Dr Anja Rockstroh

“YB-1 – a regulator of cancer progression to castrate resistance?”


Dr Anja Rockstroh

Research Fellow
Australian Prostate Cancer Research Centre – Queensland
Queensland University of Technology

 

 

 

 

 

flyer for printing

Russell Strong Auditorium
Basement Main Building, Princess Alexandra Hospital
Brisbane

Refreshments: from 4.45pm
Presentations: 5.15pm-6.15pm
Networking: 6.15pm-6:45pm

RSVP for catering purposes: prostatecentre@qut.edu.au

For information about future seminars visit our Upcoming Event listing

Proudly supported by

AstraZeneca